Suplemento II · Revista nº 814

81 Casas Maldonado F | Actualización, tratamiento y prevencion del Covid-19 Actual Med. 2021; 106(814). Supl2: 71- 82 S U P L E M E N T O C O V I D - 1 9 2. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-1207. doi: 10.1056/NEJ- Moa2001316. Epub 2020 Jan 29. 3. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infec- ted Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. 4. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19. N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMe2009758 5. World Health Organization. Coronavirus Disease 2019 (CO- VID-19): Situation Report-51. https://apps.who.int/iris/bits- tream/handle/10665/331475/ nCoVsitrep11Mar2020-eng. pdf?sequence=1&isAllowed=y 6. WHO Coronavirus (COVID-19) Dashboard. Disponible en: ht- tps://covid19.who.int/ 7. Spain situation COVID19. Disponible en: https://covid19. who.int/region/euro/country/es 8. World Health Organization (WHO). Novel coronavirus (2019-nCoV) situation report – 38, 27 February 2020. WHO Bulletin; 2020 [con- sultado 25 Jul 2020]. Disponible en: https://www.who.int/emer- gencies/diseases/novel-coronavirus-2019/situation-reports 9. Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gestión de la situación de crisis sanitaria ocasionada por el COVID-19. BOE núm. 67, de 14 de Mar de 2020; p. 25390-400 [consultado 25 Jul 2020]. Dispo- nible en: https://www.boe.es/eli/es/rd/2020/03/14/463 10. Banco de España. Escenarios macroeconómicos de refe- rencia para la economía española tras el COVID-19. Boletín Económico 2/2020 [consultado 25 Jul 2020]. Disponible en: https://www.bde.es/f/webbde/GAP/Secciones/SalaPren- sa/COVID-19/be2002-art1.pdf 11. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavi- rus disease 2019 in China. N Engl J Med 2020;382: 1708–1720. 12. Wu Z, McGoogan JM. Characteristics of and Important Les- sons From the Coronavirus Disease 2019 (COVID-19) Out- break in China. JAMA. 2020;323:1239-42. 13. Cevik M, Tate M, Lloyd O, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral she- dding, and infectiousness: a systematic review and me- ta-analysis. Lancet Microbe 2021; 2: e13–e22. 14. Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med 2020; 8:1233–1244. 15. McElvaney OJ, McEvoy NL, McElvaney OF, et al. Characte- rization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 2020; 202: 812–821. 16. Office for National Statistics. The prevalence of long CO- VID symptoms and COVID-19 complications [Internet]. [citado 14 de enero de 2021]. Disponible en: https://www. ons.gov.uk/news/statementsandletters/theprevalenceo- flongcovidsymptomsandcovid19complications 17. Ministerio de Sanidad. Centro de Coordinación de Alertas y Emergencias Sanitarias. Información clínica COVID-19. Actualización, 25 de marzo 2021- https://www.mscbs. gob.es/profesionales/saludPublica/ccayes/alertasAc- tual/nCov/documentos/Documento_CLINICA.pdf 18. Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020;173:262-7 19. Raptis CA, Hammer MM, Short RG, et al., Chest CT. and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date. AJR Am J Roentgenol. 2020;215:839- 42. 20. Martínez Chamorro E, Díez Tascón A, Ibáñez Sanz L, Os- saba Vélez S, Borruel Nacenta S. Radiologic diagnosis of patients with COVID-19. Radiologia (Engl Ed). 2021 Jan-Feb;63(1):56-73. English, Spanish. doi: 10.1016/j. rx.2020.11.001. Epub 2020 Nov 24. PMID: 33339622; PMCID: PMC7685043. 21. Ojha V, Mani A, Pandey NN, et al. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol. 2020;30:6129-38. 22. Bernheim A, Mei X, Huang M, et al. Chest CT. findings in coronavirus disease 2019 (COVID-19): Relationship to du- ration of infection. Radiology. 2020;295:200463. 23. Wilkinson T, Dixon R, Page C, et al. ACCORD: a multicen- tre, seamless, phase 2 adaptive randomisation platform study to assess the efficacy and safety of multiple candi- date agents for the treatment of COVID-19 in hospitalised patients: a structured summary of a study protocol for a randomised controlled trial. Trials 2020; 21: 691. 24. Paumgartten FJR, de Oliveira ACAX. Off label, compassio- nate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues. Cien Saude Colet 2020; 25: 3413–3419. 25. Modificada de: Chalmers JD, Crichton ML, Goeminne PC, et al. Management of hospitalised adults with coronavirus di- sease 2019 (COVID-19): a European Respiratory Society li- ving guideline. Eur Respir J. 2021 Apr 15;57(4):2100048. doi: 10.1183/13993003.00048-2021. PMID: 33692120; PMCID: PMC7947358. 26. Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wa- jnberg A, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med [Internet]. 1 de septiembre de 2020 [citado 4 de enero de 2021];8(9):e70. Disponible en: ht- tps://www.thelancet.com/journals/lanres/article/PIIS2213- 2600(20)30354-4/abstract